OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Isoliquiritigenin, a potent human monoamine oxidase inhibitor, modulates dopamine D1, D3, and vasopressin V1A receptors
Ritu Prajapati, Su Hui Seong, Se Eun Park, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 24

Showing 24 citing articles:

Natural Products Inhibitors of Monoamine Oxidases—Potential New Drug Leads for Neuroprotection, Neurological Disorders, and Neuroblastoma
Narayan D. Chaurasiya, Francisco León, Ilias Muhammad, et al.
Molecules (2022) Vol. 27, Iss. 13, pp. 4297-4297
Open Access | Times Cited: 40

Flavonoids-based nanomedicines for the treatment of liver fibrosis: A recent progress
Karthik Shree Harini, Devaraj Ezhilarasan
Journal of Drug Delivery Science and Technology (2024) Vol. 93, pp. 105467-105467
Closed Access | Times Cited: 4

Therapeutic considerations of bioactive compounds in Alzheimer's disease and Parkinson's disease: Dissecting the molecular pathways
Banashree Chetia Phukan, Rubina Roy, Indira Gahatraj, et al.
Phytotherapy Research (2023) Vol. 37, Iss. 12, pp. 5657-5699
Open Access | Times Cited: 10

Neuroprotective Effects of Glycyrrhiza glabra Total Extract and Isolated Compounds
Ali O. E. Eltahir, Sylvester I. Omoruyi, Tanya N. Augustine, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 7, pp. 852-852
Open Access | Times Cited: 3

Nature as a source and inspiration for human monoamine oxidase B (hMAO-B) inhibition: A review of the recent advances in chemical modification of natural compounds
Francesco Melfi, Simone Carradori, Andrea Angeli, et al.
Expert Opinion on Drug Discovery (2023) Vol. 18, Iss. 8, pp. 851-879
Closed Access | Times Cited: 8

Natural Chalcones for the Management of Obesity Disease
Maria Maisto, A Marzocchi, Niloufar Keivani, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 21, pp. 15929-15929
Open Access | Times Cited: 8

LC/ESI/TOF-MS Characterization, Anxiolytic and Antidepressant-like Effects of Mitragyna speciosa Korth Extract in Diabetic Rats
Lin Chen, Shizao Fei, Opeyemi Joshua Olatunji
Molecules (2022) Vol. 27, Iss. 7, pp. 2208-2208
Open Access | Times Cited: 11

Structure-Based Profiling of Potential Phytomolecules with AKT1 a Key Cancer Drug Target
Zeenat Mirza, Sajjad Karim
Molecules (2023) Vol. 28, Iss. 6, pp. 2597-2597
Open Access | Times Cited: 6

Isoliquiritigenin regulates microglial M1/M2 polarisation by mediating the P38/MAPK pathway in cerebral stroke
Ruixia Wang, Weili Zhang
Journal of Pharmacy and Pharmacology (2023) Vol. 75, Iss. 6, pp. 828-836
Closed Access | Times Cited: 5

Targeting Endoplasmic Reticulum Stress by Natural and Chemical Compounds Ameliorates Cisplatin-Induced Nephrotoxicity: A Review
Habibeh Mashayekhi‐Sardoo, Ramin Rezaee, Fatemeh Yarmohammadi, et al.
Biological Trace Element Research (2024)
Closed Access | Times Cited: 1

Shenling Baizhu San Alleviates Central Fatigue through SIRT1-PGC-1α-Mediated Mitochondrial Biogenesis
R.J. Wang, Yan Liu, Yang Jiang, et al.
Journal of Ethnopharmacology (2024), pp. 119110-119110
Closed Access | Times Cited: 1

Isoliquiritigenin Protects Neuronal Cells against Glutamate Excitotoxicity
Arina Zgodova, С. И. Павлова, Anastasia Nekrasova, et al.
Membranes (2022) Vol. 12, Iss. 11, pp. 1052-1052
Open Access | Times Cited: 8

Isoliquiritigenin attenuates neuroinflammation in mice model of Parkinson’s disease by promoting Nrf2/NQO-1 pathway
Lijuan Huang, Han Yan, Qingmin Zhou, et al.
Translational Neuroscience (2022) Vol. 13, Iss. 1, pp. 301-308
Open Access | Times Cited: 5

Targeting chalcone binding sites in living Leishmania using a reversible fluorogenic benzochalcone probe
Ariane de Jesus Sousa‐Batista, Suellen Darc Oliveira, Sébastien Pomel, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 149, pp. 112784-112784
Open Access | Times Cited: 4

DendroX: multi-level multi-cluster selection in dendrograms
Feiling Feng, Qiaonan Duan, Xiaoqing Jiang, et al.
BMC Genomics (2024) Vol. 25, Iss. 1
Open Access

Natural Product-Inspired Dopamine Receptor Ligands
Michael Dorogan, Namballa Hari Krishna, Wayne W. Harding
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 15, pp. 12463-12484
Open Access

Phytochemicals with epigenetic properties and their role in melanoma therapy
Ioannis Anestopoulos, Sotiris Kyriakou, Maria V. Deligiorgi, et al.
International review of cell and molecular biology (2024)
Closed Access

Unveiling the Essence of Isoliquiritigenin: Exploring Its Chemistry, Pharmacokinetics, and Pharmacological Potential
P. Mohamed Nihal, Debasish Mohapatra, Alam Mohd Adil Alam Manir, et al.
Chemistry Africa (2024)
Closed Access

Computational Modeling of MAO Inhibitors as Anti-Alzheimer Agents
Gurmeet Kaur, Deepti Goyal, Bhupesh Goyal
Neuromethods (2023), pp. 325-353
Closed Access | Times Cited: 1

Isoliquiritigenin modulates the activity of LTS and non-LTS cells in the ventrolateral preoptic area via GABAA receptors
Sumei Fan, Qiaoling Jin, Ping Zhang, et al.
Heliyon (2023) Vol. 9, Iss. 10, pp. e20620-e20620
Open Access | Times Cited: 1

Page 1

Scroll to top